-
41
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
Published 2024-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
42
-
43
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
44
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer
Published 2025-02-01Subjects: Get full text
Article -
45
The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential
Published 2024-12-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
46
Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
47
Abnormal expression of miR-668-3p in non-small cell lung cancer patients and its correlation with serum-related tumor markers
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
48
-
49
J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
Published 2025-03-01Subjects: “…Extensive-stage small cell lung cancer…”
Get full text
Article -
50
Sarcoidosis and Non-small Cell Lung Cancer: Expression of miR-145, miR-301, and miR-449
Published 2024-12-01Subjects: Get full text
Article -
51
Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
52
Preclinical evaluation and preliminary clinical study of 68Ga-NODAGA-NM-01 for PET imaging of PD-L1 expression
Published 2025-01-01Subjects: Get full text
Article -
53
Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
54
Periostin-mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancer
Published 2025-01-01Subjects: “…Small cell lung cancer…”
Get full text
Article -
55
-
56
Efficacy and safety of anlotinib as maintenance treatment in extensive-stage small cell lung cancer: a single-armed single center retrospective study
Published 2025-01-01Subjects: “…extensive-stage small cell lung cancer…”
Get full text
Article -
57
Oxymatrine inhibits the development of radioresistance in NSCLC cells by reversing EMT through the DcR3/AKT/GSK-3β pathway
Published 2023-01-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
58
Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
59
Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 01...
Published 2025-01-01Subjects: “…Non-Small-Cell Lung Cancer…”
Get full text
Article -
60
Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Published 2025-02-01Subjects: Get full text
Article